Literature DB >> 33772862

'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.

Molly L Tanenbaum1,2, Dessi P Zaharieva1, Ananta Addala1, Jessica Ngo1, Priya Prahalad1, Brianna Leverenz1, Christin New1, David M Maahs1,2, Korey K Hood1,2.   

Abstract

AIM: This study aimed to capture the experience of parents of youth with recent onset Type 1 diabetes who initiated use of continuous glucose monitoring (CGM) technology soon after diagnosis, which is a new practice.
METHODS: Focus groups and individual interviews were conducted with parents of youth with Type 1 diabetes who had early initiation of CGM as part of a new clinical protocol. Interviewers used a semi-structured interview guide to elicit feedback and experiences with starting CGM within 30 days of diagnosis, and the benefits and barriers they experienced when adjusting to this technology. Groups and interviews were audio recorded, transcribed and analysed using content analysis.
RESULTS: Participants were 16 parents (age 44.13 ± 8.43 years; 75% female; 56.25% non-Hispanic White) of youth (age 12.38 ± 4.15 years; 50% female; 50% non-Hispanic White; diabetes duration 10.35 ± 3.89 months) who initiated CGM 11.31 ± 7.33 days after diabetes diagnosis. Overall, parents reported high levels of satisfaction with starting CGM within a month of diagnosis and described a high level of reliance on the technology to help manage their child's diabetes. All participants recommended early CGM initiation for future families and were committed to continue using the technology for the foreseeable future, provided that insurance covered it.
CONCLUSION: Parents experienced CGM initiation shortly after their child's Type 1 diabetes diagnosis as a highly beneficial and essential part of adjusting to living with diabetes.
© 2021 Diabetes UK.

Entities:  

Keywords:  children and adolescents; devices; health care delivery; psychological aspects

Mesh:

Substances:

Year:  2021        PMID: 33772862      PMCID: PMC8480902          DOI: 10.1111/dme.14567

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  29 in total

1.  The precision medicine initiative: a new national effort.

Authors:  Euan A Ashley
Journal:  JAMA       Date:  2015-06-02       Impact factor: 56.272

2.  COVID-19 and Children With Diabetes-Updates, Unknowns, and Next Steps: First, Do No Extrapolation.

Authors:  Linda A DiMeglio; Anastasia Albanese-O'Neill; Cynthia E Muñoz; David M Maahs
Journal:  Diabetes Care       Date:  2020-09-04       Impact factor: 19.112

3.  CGM Initiation Soon After Type 1 Diabetes Diagnosis Results in Sustained CGM Use and Wear Time.

Authors:  Priya Prahalad; Ananta Addala; David Scheinker; Korey K Hood; David M Maahs
Journal:  Diabetes Care       Date:  2019-09-26       Impact factor: 19.112

4.  Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance.

Authors:  Ananta Addala; David M Maahs; David Scheinker; Solana Chertow; Brianna Leverenz; Priya Prahalad
Journal:  Pediatr Diabetes       Date:  2020-08-10       Impact factor: 4.866

5.  Continuous Glucose Monitoring in Adolescent, Young Adult, and Older Patients With Type 1 Diabetes.

Authors:  Shivani Agarwal; Anne R Cappola
Journal:  JAMA       Date:  2020-06-16       Impact factor: 56.272

6.  Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified.

Authors:  John E Anderson; James R Gavin; Davida F Kruger
Journal:  Diabetes Technol Ther       Date:  2019-10-21       Impact factor: 6.118

7.  A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison.

Authors:  Ananta Addala; Marie Auzanneau; Kellee Miller; Werner Maier; Nicole Foster; Thomas Kapellen; Ashby Walker; Joachim Rosenbauer; David M Maahs; Reinhard W Holl
Journal:  Diabetes Care       Date:  2020-09-16       Impact factor: 19.112

8.  Using the framework method for the analysis of qualitative data in multi-disciplinary health research.

Authors:  Nicola K Gale; Gemma Heath; Elaine Cameron; Sabina Rashid; Sabi Redwood
Journal:  BMC Med Res Methodol       Date:  2013-09-18       Impact factor: 4.615

9.  Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys.

Authors:  Robert Engler; Timothy L Routh; Joseph Y Lucisano
Journal:  Clin Diabetes       Date:  2018-01

Review 10.  Improving Clinical Outcomes in Newly Diagnosed Pediatric Type 1 Diabetes: Teamwork, Targets, Technology, and Tight Control-The 4T Study.

Authors:  Priya Prahalad; Dessi P Zaharieva; Ananta Addala; Christin New; David Scheinker; Manisha Desai; Korey K Hood; David M Maahs
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-09       Impact factor: 5.555

View more
  7 in total

1.  Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.

Authors:  Priya Prahalad; Victoria Y Ding; Dessi P Zaharieva; Ananta Addala; Ramesh Johari; David Scheinker; Manisha Desai; Korey Hood; David M Maahs
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 2.  Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes.

Authors:  Dessi P Zaharieva; Franziska K Bishop; David M Maahs
Journal:  Curr Opin Pediatr       Date:  2022-08-01       Impact factor: 2.893

3.  'Much more convenient, just as effective': Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.

Authors:  Molly L Tanenbaum; Dessi P Zaharieva; Ananta Addala; Priya Prahalad; Julie A Hooper; Brianna Leverenz; Ana L Cortes; Nora Arrizon-Ruiz; Erica Pang; Franziska Bishop; David M Maahs
Journal:  Diabet Med       Date:  2022-08-08       Impact factor: 4.213

4.  Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.

Authors:  Molly L Tanenbaum; Laurel H Messer; Christine A Wu; Marina Basina; Bruce A Buckingham; Danielle Hessler; Shelagh A Mulvaney; David M Maahs; Korey K Hood
Journal:  Diabetes Res Clin Pract       Date:  2021-09-14       Impact factor: 8.180

Review 5.  Psychosocial Needs for Newly Diagnosed Youth with Type 1 Diabetes and Their Families.

Authors:  Susana R Patton; David Maahs; Priya Prahalad; Mark A Clements
Journal:  Curr Diab Rep       Date:  2022-06-21       Impact factor: 5.430

Review 6.  Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Authors:  Molly L Tanenbaum; Persis V Commissariat
Journal:  Curr Diab Rep       Date:  2022-05-06       Impact factor: 5.430

7.  Clinically Serious Hypoglycemia Is Rare and Not Associated With Time-in-range in Youth With New-onset Type 1 Diabetes.

Authors:  Ananta Addala; Dessi P Zaharieva; Angela J Gu; Priya Prahalad; David Scheinker; Bruce Buckingham; Korey K Hood; David M Maahs
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.